Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathy.

dc.contributor.author	Kose, Murat
dc.contributor.author	Simsek Yavuz, Serap
dc.contributor.author	Eraksoy, Haluk
dc.contributor.author	Tukek, Tufan
dc.contributor.author	Senkal, Naci
dc.contributor.author	Kalayoglu Besisik, Sevgi
dc.contributor.author	Ozbalak, Murat
dc.contributor.author	Tor, Yavuz Burak
dc.contributor.author	Medetalibeyoglu, Alpay
dc.contributor.author	Cagatay, Atahan
dc.contributor.author	Erelel, Mustafa
dc.contributor.author	Gul, Ahmet
dc.contributor.author	Esen, Figen
dc.date.accessioned	2023-02-21T09:26:14Z
dc.date.available	2023-02-21T09:26:14Z
dc.date.issued	2022
dc.identifier.citation	Kalayoglu Besisik S., Ozbalak M., Tor Y. B., Medetalibeyoglu A., Kose M., Senkal N., Cagatay A., Erelel M., Gul A., Esen F., et al., "Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathy.", American journal of blood research, cilt.12, sa.2, ss.54-59, 2022
dc.identifier.other	vv_1032021
dc.identifier.other	av_2e113023-7c93-4c62-9983-adf859d59bb0
dc.identifier.uri	http://hdl.handle.net/20.500.12627/187483
dc.language.iso	eng
dc.title	Dipyridamole does not have any additive effect on the prevention of COVID-19 coagulopathy.
dc.type	Makale
dc.relation.journal	American journal of blood research
dc.contributor.department	İstanbul Üniversitesi , İstanbul Tıp Fakültesi , İstanbul Tıp Fakültesi Başhekimlik
dc.identifier.volume	12
dc.identifier.issue	2
dc.identifier.startpage	54
dc.identifier.endpage	59
dc.contributor.firstauthorID	3439304

Files in this item

Files	Size	Format	View
There are no files associated with this item.